AI assistant
INTUITIVE SURGICAL INC — Director's Dealing 2024
Oct 31, 2024
29809_dirs_2024-10-31_05e06f8d-4ae7-49c7-ae73-03db55450dd3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INTUITIVE SURGICAL INC (ISRG)
CIK: 0001035267
Period of Report: 2024-10-30
Reporting Person: GUTHART GARY S (Director, CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-10-30 | Common Stock | M | 25200 | $59.2278 | Acquired | 42370 | Direct |
| 2024-10-30 | Common Stock | S | 18151 | $511.6343 | Disposed | 24219 | Direct |
| 2024-10-30 | Common Stock | S | 3720 | $510.5179 | Disposed | 19920 | Indirect |
| 2024-10-30 | Common Stock | S | 3720 | $510.7534 | Disposed | 19920 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-10-30 | Non-Qualified Stock Option (right to buy) | $59.2278 | M | 25200 | Disposed | 2025-08-17 | Common Stock (25200) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1191144 | Indirect |
Footnotes
F1: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on April 30, 2025.
F2: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $508.66 to $516.87 as follows: 1,504 shares sold at $508.66 to $509.50; 8,289 shares sold at $509.67 to $510.63; 3,083 shares sold at $510.68 to $511.54; 775 shares sold at $511.91to $512.30; 599 shares sold at $513.14 to $514.09; 1,728 shares sold at $514.28 to $515.26; 274 shares sold at $515.38 to $515.99; and 1,899 shares sold at $516.56 to $516.87. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F3: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $508.51 to $516.31 as follows: 415 shares sold at $508.51 to $509.24; 1,993 shares sold at $509.53 to $510.49; 693 shares sold at $510.54 to $510.93; 320 shares sold at $511.57 to $512.22; 127 shares sold at $512.61 to $512.74; 100 shares sold at $514.47; and 72 shares sold at $516.31. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F4: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $508.52 to $516.67 as follows: 388 shares sold at $508.52 to $509.06; 1,698 shares sold at $509.53 to $510.49; 1,155 shares sold at $510.63 to $511.54; 215 shares sold at $511.84 to $512.76; and 264 shares sold at $516.31 to $516.67. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F5: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.